WWW - Posts tagged Cubist pharmaceuticals at BloggingStocks

cubist pharmaceuticals posts

Analyst upgrades, downgrades and initiations

Analyst upgrades:

Jefferies upgraded shares of Anadarko Petroleum Corporation (NYSE: APC) to Buy from Hold and raised the target to $79 from $52.50 on valuation and believes the company can use its strong cash flow position to acquire assets.
Baird said The Corporate Executive Board Company's (NASDAQ: EXBD) valuation is discounting a miss and that the company is well positioned as an early-cycle story with a new CFO, continued mid-market traction, and likely better than feared 2009 results. The firm upgraded shares to Outperform from Neutral and raised its target to $38 from $41.
Merrill upgraded Novartis AG (ADR) (NYSE: NVS) to Buy from Neutral and Sanofi-Aventis SA (ADR) (NYSE: SNY) and Shire Plc (ADR) (NASDAQ: SHPGY) to Buy from Underperform on valuation and defensive earnings.
Marshall & Ilsley Corporation (NYSE: MI) was upgraded to Market Perform from Underperform at Keefe Bruyette.
Barclays Plc (ADR) (NYSE: BCS) was raised to Hold from Sell at Citigroup.
Novellus Systems, Inc. (NASDAQ: NVLS) was upgraded at Soleil to Buy from Hold.